Comprehensive landscape and future perspectives of PIWI‑interacting RNAs in cancer (Review)
International Journal of Oncology · 09.10.2026 · 69 (5) · 1-21
DOI: 10.3892/ijo.2026.5946 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 09.10.2026. Verfasst von Xiaoqian Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China. Hauptthemen laut MEDLINE: Piwi-Interacting RNA, Neoplasms, Biomarkers, Tumor, RNA, Small Interfering. Die Arbeit nennt 190 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
P‑element induced wimpy testis (PIWI)‑interacting RNAs (piRNAs) are small non‑coding RNAs with a length of ~24‑32 nucleotides that specifically bind members of the PIWI protein family. Initially identified in germ cells, piRNAs have since been detected in various somatic cells. They regulate multiple physiological and pathological processes and their aberrant expression contributes to human diseases, including cancer. Recent studies indicate that piRNAs influence key tumour behaviours‑including malignant proliferation, invasion and metastasis, angiogenesis, immune evasion and metabolic reprogramming‑through epigenetic, transcriptional and post‑transcriptional mechanisms. In tumour‑bearing mouse models, exogenous knockdown or overexpression of piRNAs using nanodelivery systems can markedly inhibit tumour growth, supporting their potential as therapeutic targets. piRNAs are also stably expressed in tumour tissues and bodily fluids, such as serum and urine, either freely circulating or encapsulated within extracellular vesicles; their dysregulation is associated with clinicopathological features of tumours. Accordingly, piRNAs may serve as novel pathological diagnostic markers or liquid biopsy biomarkers. This review summarises piRNA expression patterns and molecular mechanisms, evaluates their clinical potential in cancer diagnosis and treatment and integrates advances in high‑throughput sequencing and nanodelivery technologies to provide a theoretical basis and research foundation for the clinical translation of piRNA‑related studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
- Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
- Departments of Ultrasound Imaging, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
- Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
- Department of Urology, The Affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410005, P.R. China.
Zitieren
APA
Yu, X., Li, C., Zhuang, T., Sun, S., He, X., Ou, Z., Li, N., & Ou, C. (2026). Comprehensive landscape and future perspectives of PIWI‑interacting RNAs in cancer (Review). International Journal of Oncology, 69(5), 1-21. https://doi.org/10.3892/ijo.2026.5946
Vancouver
Yu X, Li C, Zhuang T, Sun S, He X, Ou Z, et al. Comprehensive landscape and future perspectives of PIWI‑interacting RNAs in cancer (Review). International Journal of Oncology. 2026;69(5):1-21. doi:10.3892/ijo.2026.5946
BibTeX
@article{Yu2026,
author = {Yu, Xiaoqian and Li, Changlong and Zhuang, Tongtao and Sun, Siqing and He, Xiaoyun and Ou, Zhenyu and Li, Nannan and Ou, Chunlin},
title = {Comprehensive landscape and future perspectives of PIWI‑interacting RNAs in cancer (Review)},
journal = {International Journal of Oncology},
year = {2026},
volume = {69},
number = {5},
pages = {1--21},
doi = {10.3892/ijo.2026.5946}
}
EUVIMED